RESP-X

GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

Home
Ligands
RESP-X

GtoPdb Ligand ID: 14217

Synonyms: COT-143 | INFEX702

Compound class: Antibody

Comment: RESP-X is a humanized monoclonal antibody targeting the PcrV protein of Pseudomonas aeruginosa. It is being developed as an anti-virulence therapy for P. aeruginosa infections in patients with non-cystic fibrosis bronchiectasis.

Summary
Biological activity
Clinical data
References

No information available.

No information available.

Summary of Clinical Use
A phase 1 study has been registered with the UK's Clinical Study Registry (ID ISRCTN17978477) to evaluate the safety and efficacy of RESP-X in healthy subjects and non-cystic fibrosis bronchiectasis patients colonized with P. aeruginosa.

Summary of Clinical Use

A phase 1 study has been registered with the UK's Clinical Study Registry (ID ISRCTN17978477) to evaluate the safety and efficacy of RESP-X in healthy subjects and non-cystic fibrosis bronchiectasis patients colonized with P. aeruginosa.